HK1205680A1 - 用於治療丙型肝炎病毒的藥劑 - Google Patents

用於治療丙型肝炎病毒的藥劑

Info

Publication number
HK1205680A1
HK1205680A1 HK15106192.6A HK15106192A HK1205680A1 HK 1205680 A1 HK1205680 A1 HK 1205680A1 HK 15106192 A HK15106192 A HK 15106192A HK 1205680 A1 HK1205680 A1 HK 1205680A1
Authority
HK
Hong Kong
Prior art keywords
hepatitis
virus
agent
treatment
Prior art date
Application number
HK15106192.6A
Other languages
English (en)
Inventor
弗拉迪米爾.葉夫根尼耶維奇.涅博利辛
德米特里.尤里耶維奇.康斯坦丁諾夫
拉里莎.列昂尼多夫娜.波波娃
葉連娜.阿列克謝夫娜.斯特列布科娃
彼得.格里戈里耶維奇.杰里亞賓
Original Assignee
Obschestvo S Ogranichennoi Otvetstvennostiyu Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Obschestvo S Ogranichennoi Otvetstvennostiyu Pharm filed Critical Obschestvo S Ogranichennoi Otvetstvennostiyu Pharm
Publication of HK1205680A1 publication Critical patent/HK1205680A1/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/417Imidazole-alkylamines, e.g. histamine, phentolamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05Dipeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • A61K38/212IFN-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
HK15106192.6A 2012-03-14 2015-06-30 用於治療丙型肝炎病毒的藥劑 HK1205680A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2012109938/15A RU2496512C1 (ru) 2012-03-14 2012-03-14 Способ лечения вирусного гепатита с
PCT/RU2013/000193 WO2013137782A1 (ru) 2012-03-14 2013-03-13 Средство для лечения вирусного гепатита с

Publications (1)

Publication Number Publication Date
HK1205680A1 true HK1205680A1 (zh) 2015-12-24

Family

ID=49161554

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15106192.6A HK1205680A1 (zh) 2012-03-14 2015-06-30 用於治療丙型肝炎病毒的藥劑

Country Status (7)

Country Link
US (1) US9351960B2 (zh)
EP (1) EP2826486A4 (zh)
CN (1) CN104284670B (zh)
EA (1) EA029380B1 (zh)
HK (1) HK1205680A1 (zh)
RU (1) RU2496512C1 (zh)
WO (1) WO2013137782A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2518314C2 (ru) * 2012-08-30 2014-06-10 Общество С Ограниченной Ответственностью "Фарминтерпрайсез" Способ и средство активации irf-3 для лечения и профилактики заболеваний, вызываемых (+) phk-содержащими вирусами

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2141483C1 (ru) * 1997-07-04 1999-11-20 Небольсин Владимир Евгеньевич Производные пептидов или их фармацевтически приемлемые соли, способ их получения, применение и фармацевтическая композиция
RU2378284C2 (ru) * 2008-02-13 2010-01-10 Общество С Ограниченной Ответственностью "Фарминтерпрайсез" Способы получения n-ацильных производных аминокислот (варианты)
WO2010033841A1 (en) * 2008-09-19 2010-03-25 Globeimmune, Inc. Immunotherapy for chronic hepatitis c virus infection
US9504673B2 (en) * 2009-05-21 2016-11-29 LTD “Valenta-Intellekt” Agent for the prophylaxis and treatment of highly pathogenic infectious diseases

Also Published As

Publication number Publication date
US9351960B2 (en) 2016-05-31
EA029380B1 (ru) 2018-03-30
RU2496512C1 (ru) 2013-10-27
CN104284670A (zh) 2015-01-14
US20150064135A1 (en) 2015-03-05
EP2826486A1 (en) 2015-01-21
RU2012109938A (ru) 2013-09-20
WO2013137782A1 (ru) 2013-09-19
EA201491652A1 (ru) 2014-12-30
EP2826486A4 (en) 2015-11-18
CN104284670B (zh) 2017-08-29

Similar Documents

Publication Publication Date Title
IL269662A (en) Hepatitis C virus inhibitors
IL253225A0 (en) Sulfamoyl-arylamides and their use as drugs to treat jaundice b
HK1211589A1 (zh) 用於治療副粘病毒病毒性感染的化合物
ZA201405820B (en) Piperidino-pyrimidine derivatives for the treatment of viral infections
ZA201500921B (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diaseases
ZA201404061B (en) Compositions and methods for treating the hepatitis c virus
HK1210022A1 (zh) 治療乙型肝炎及丁型肝炎感染的方法
HK1212332A1 (zh) 丙型肝炎病毒抑制劑
HK1205680A1 (zh) 用於治療丙型肝炎病毒的藥劑
GB201114710D0 (en) Treatment of hepatitis c